Financial reports
N-CEN
Annual report (registered investment company)
14 Mar 24
N-CSR
Certified annual shareholder report (management investment company)
6 Mar 24
N-CSRS
Certified semi-annual shareholder report (management investment company)
1 Sep 23
N-CEN
Annual report (registered investment company)
10 Mar 23
N-CSR
Certified annual shareholder report (management investment company)
7 Mar 23
N-CSRS
Certified semi-annual shareholder report (management investment company)
1 Sep 22
N-CEN
Annual report (registered investment company)
15 Mar 22
N-CSR
Certified annual shareholder report (management investment company)
4 Mar 22
N-CSRS
Certified semi-annual shareholder report (management investment company)
2 Sep 21
N-CEN
Annual report (registered investment company)
15 Mar 21
Current reports
8-K
Regulation FD Disclosure
28 Oct 16
8-K
BlackRock Closed-End Funds Announce Date of 2011 Annual Meeting of Shareholders
4 Feb 11
8-K
Regulation FD Disclosure
29 Oct 10
8-K
Regulation FD Disclosure
7 Oct 08
8-K
Certain BlackRock Closed-End Funds Announce Shareholder Proposal Submission Date
31 May 07
Registration and prospectus
424B3
Prospectus supplement
26 Jun 23
424B3
Prospectus supplement
3 Jan 23
424B3
Prospectus supplement
15 Jul 22
POS EX
Additional exhibits for listing
26 Apr 22
424B2
Prospectus for primary offering
26 Apr 22
424B2
Prospectus for primary offering
30 Apr 21
424B3
Prospectus supplement
27 Aug 20
8-A12B
Registration of securities on exchange
24 Mar 05
Proxies
N-PX
Annual report of proxy voting record
25 Aug 23
DEF 14A
Definitive proxy
23 May 23
N-PX
Annual report of proxy voting record
25 Aug 22
DEF 14A
Definitive proxy
3 Jun 22
N-PX
Annual report of proxy voting record
27 Aug 21
DEFA14A
Additional proxy soliciting materials
20 Jul 21
DEF 14A
Definitive proxy
8 Jun 21
N-PX
Annual report of proxy voting record
27 Aug 20
DEF 14A
Definitive proxy
9 Jun 20
N-PX
Annual report of proxy voting record
29 Aug 19
Other
CORRESP
Correspondence with SEC
4 Aug 23
EFFECT
Notice of effectiveness
26 Apr 22
CORRESP
Correspondence with SEC
21 Apr 22
EFFECT
Notice of effectiveness
29 Apr 19
CORRESP
Correspondence with SEC
24 Apr 19
CORRESP
Correspondence with SEC
19 Apr 19
CORRESP
Correspondence with SEC
3 Apr 17
EFFECT
Notice of effectiveness
8 Jun 16
CORRESP
Correspondence with SEC
7 Jun 16
CORRESP
Correspondence with SEC
7 Jun 16
Ownership
4/A
Kyle McClements
30 Apr 24
NPORT-P
BlackRock Health Sciences Trust (Dec 2023 report)
26 Feb 24
4
Kyle McClements
2 Feb 24
4
H Erin Xie
2 Feb 24
4
Christopher Accettella
2 Feb 24
4
Xiang Liu
2 Feb 24
NPORT-P
BlackRock Health Sciences Trust (Sep 2023 report)
28 Nov 23
3
Arthur Philip Steinmetz
14 Sep 23
NPORT-P
BlackRock Health Sciences Trust (Jun 2023 report)
25 Aug 23
3
Aaron David Wasserman
6 Jul 23